SAVE THE DATE
LCZ696 PARADIGM-HF trial conference call
We would like to invite you to a live meeting and audiocast following the presentation at ESC 2014
of the PARADIGM-HF trial results of LCZ696 in chronic heart failure.
This event will be hosted by David Epstein, Head Novartis Pharmaceuticals.
| When : | Sunday, August 31, 2014 - 17.00 h CEST | |
| Venue : | Hotel Porta Fira (across Congress Center main entrance) Plaza Europa, 45-47, 08908 Hospitalet de Llobregat, Barcelona, Spain Meeting room: Santemar | |
| Dial-in : | Local - UK / International | +44(0)20 3427 1913 |
| Local - Germany | +49(0)69 2222 10619 | |
| Local - Switzerland | +41(0)22 567 5431 | |
| Local - France | +33(0)1 76 77 22 31 | |
| Toll free phone - USA | +1 877 280 1254 | |
| Participant Passcode | 6803006 | |
We would appreciate if you could confirm whether you plan to attend this event in person in Barcelona.
With kind regards
Investor Relations
Novartis Global Investor Relations / General phone: +41 61 324 79 44
Samir Shah / Global Head Investor Relations +41 61 324 79 44
| Basel Office | North America Office | ||
| Pierre-Michel Bringer Thomas Hungerbuehler Isabella Zinck | +41 61 324 10 65 +41 61 324 84 25 +41 61 324 71 88 | Stephen Rubino Susan Donofrio | +1 862 778 83 01 +1 862 778 92 57 |
e-mail: investor.relations@novartis.com | www.novartis.com